Literature DB >> 7982791

Immunohistochemical localization of blood-retinal barrier breakdown sites associated with post-surgical macular oedema.

S A Vinores1, A Amin, N L Derevjanik, W R Green, P A Campochiaro.   

Abstract

Post-surgical macular oedema results from blood-retinal barrier breakdown, but it is not accompanied by structural abnormalities in the retinal vessels or retinal pigmented epithelium. Previous studies, using horseradish peroxidase in a primate model, suggested that leakage occurs primarily through this epithelium. This study was conducted to localize sites of the barrier breakdown in humans following different types of intra-ocular surgery and to compare them with eyes affected with ocular inflammatory disease, ocular infection, and choroidal melanoma. Paraffin sections of eyes were immunohistochemically stained for albumin to localize extravascular albumin, which was graded in a masked study. With aphakia/pseudophakia, penetrating keratoplasty, ocular inflammatory disease, ocular infection, and choroidal melanoma, barrier breakdown occurred primarily at the inner blood-retinal barrier (retinal vasculature), but leakage also occurred at the outer barrier (retinal pigmented epithelium). After retinal re-attachment surgery, the inner and outer blood-retinal barriers were equally compromised. Vascular leakage in the optic nerve head coincided with barrier failure in these disorders. The widespread pattern of blood-retinal barrier compromise with leakage at multiple sites suggests that soluble mediators are likely to play a role in postsurgical macular oedema, ocular inflammatory disease, and choroidal melanoma.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7982791     DOI: 10.1007/BF00158291

Source DB:  PubMed          Journal:  Histochem J        ISSN: 0018-2214


  33 in total

1.  The release of PGE2-like activity into aqueous humor after paracentesis and its prevention by aspirin.

Authors:  J D Miller; K E Eakins; M Atwal
Journal:  Invest Ophthalmol       Date:  1973-12

2.  Macular edema after cataract extraction.

Authors:  A R Irvine; R Bresky; B M Crowder; R K Forster; D M Hunter; S M Kulvin
Journal:  Ann Ophthalmol       Date:  1971-11

3.  Follow-up study of cystoid macular edema following cataract extraction.

Authors:  J D Gass; E W Norton
Journal:  Trans Am Acad Ophthalmol Otolaryngol       Date:  1969 Jul-Aug

Review 4.  Cystoid maculopathy.

Authors:  A R Irvine
Journal:  Surv Ophthalmol       Date:  1976 Jul-Aug       Impact factor: 6.048

5.  Incidence of cystoid macular edema following scleral buckling procedure.

Authors:  L A Lobes; M G Grand
Journal:  Arch Ophthalmol       Date:  1980-07

6.  Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis.

Authors:  D T Connolly; D M Heuvelman; R Nelson; J V Olander; B L Eppley; J J Delfino; N R Siegel; R M Leimgruber; J Feder
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

7.  Vitreous traction at the posterior pole of the fundus due to alterations in the vitreous posterior.

Authors:  N S Jaffe
Journal:  Trans Am Acad Ophthalmol Otolaryngol       Date:  1967 Jul-Aug

8.  Cystoid macular edema after retinal detachment surgery.

Authors:  T A Meredith; F H Reeser; T M Topping; T M Aaberg
Journal:  Ophthalmology       Date:  1980-11       Impact factor: 12.079

Review 9.  Aphakic cystoid macular edema. The pharmacology of ocular trauma.

Authors:  M L Sears
Journal:  Surv Ophthalmol       Date:  1984-05       Impact factor: 6.048

10.  Vascular permeability induced by protein product of malignant brain tumors: inhibition by dexamethasone.

Authors:  J N Bruce; G R Criscuolo; M J Merrill; R R Moquin; J B Blacklock; E H Oldfield
Journal:  J Neurosurg       Date:  1987-12       Impact factor: 5.115

View more
  15 in total

Review 1.  Macular oedema: the role of soluble mediators.

Authors:  D Kent; S A Vinores; P A Campochiaro
Journal:  Br J Ophthalmol       Date:  2000-05       Impact factor: 4.638

2.  Bacillus cereus-induced permeability of the blood-ocular barrier during experimental endophthalmitis.

Authors:  Andrea L Moyer; Raniyah T Ramadan; Billy D Novosad; Roger Astley; Michelle C Callegan
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-03-05       Impact factor: 4.799

3.  AAV8-vectored suprachoroidal gene transfer produces widespread ocular transgene expression.

Authors:  Kun Ding; Jikui Shen; Zibran Hafiz; Sean F Hackett; Raquel Lima E Silva; Mahmood Khan; Valeria E Lorenc; Daiqin Chen; Rishi Chadha; Minie Zhang; Sherri Van Everen; Nicholas Buss; Michele Fiscella; Olivier Danos; Peter A Campochiaro
Journal:  J Clin Invest       Date:  2019-08-13       Impact factor: 14.808

Review 4.  Mechanisms of fluid accumulation in retinal edema.

Authors:  M F Marmor
Journal:  Doc Ophthalmol       Date:  1999       Impact factor: 2.379

Review 5.  Cellular mechanisms of blood-retinal barrier dysfunction in macular edema.

Authors:  S A Vinores; N L Derevjanik; H Ozaki; N Okamoto; P A Campochiaro
Journal:  Doc Ophthalmol       Date:  1999       Impact factor: 2.379

6.  Thrombin regulates chemokine induction during human retinal pigment epithelial cell/monocyte interaction.

Authors:  A Yoshida; S G Elner; Z M Bian; S L Kunkel; N W Lukacs; V M Elner
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

Review 7.  Light damage revisited: converging evidence, diverging views?

Authors:  C Remé; J Reinboth; M Clausen; F Hafezi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-01       Impact factor: 3.117

8.  Extrafoveal traction in retinal vein occlusion using spectral domain optical coherence tomography.

Authors:  Michael R Martinez; Avinoam Ophir
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-04-07       Impact factor: 3.117

9.  Intraocular and plasma levels of cellular fibronectin in patients with uveitis and diabetes mellitus.

Authors:  K Probst; R Fijnheer; P Schellekens; A Rothova
Journal:  Br J Ophthalmol       Date:  2004-05       Impact factor: 4.638

10.  Bacillus cereus induces permeability of an in vitro blood-retina barrier.

Authors:  A L Moyer; R T Ramadan; J Thurman; A Burroughs; M C Callegan
Journal:  Infect Immun       Date:  2008-02-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.